Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05753722 |
Title | A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Parthenon Therapeutics, Inc. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Yale Cancer Center | RECRUITING | New Haven | Connecticut | 06511 | United States | Details |
Mass General Cancer Center | RECRUITING | Boston | Massachusetts | 02114 | United States | Details |
Providence Cancer Institute Franz Clinic | RECRUITING | Portland | Oregon | 97213 | United States | Details |
University of Pittsburgh Medical Center Hillman Cancer Center | RECRUITING | Pittsburgh | Pennsylvania | 15232 | United States | Details |
Vanderbilt-Ingram Cancer Center | RECRUITING | Nashville | Tennessee | 27232 | United States | Details |
The University of Texas MD Anderson Cancer Center | RECRUITING | Houston | Texas | 77030 | United States | Details |
Next Oncology | RECRUITING | Irving | Texas | 75039 | United States | Details |
NEXT Oncology | RECRUITING | San Antonio | Texas | 78229 | United States | Details |
Next Oncology | RECRUITING | Fairfax | Virginia | 22031 | United States | Details |